Homo sapiens
SU-DHL-4 and SU-DHL-10 DLBCL cells were seeded 18 hours prior to treatment with either DMSO or one of three CDK9 inhibitors: VIP152 (0.25 or 1 μM), atuveciclib (1 μM), or KB-0742 (1 μM).
drug treatment and replicate
Enito250 replicate 2
dosing timepoint
28-52hr
isolate
not applicable
age
not applicable
biomaterial_provider
not applicable
collection_date
not applicable
geo_loc_name
not applicable
sex
not applicable
tissue
not applicable
cell_line
SUDHL-4
cell_subtype
not provided
cell_type
not provided
culture_collection
not provided
dev_stage
not provided
disease
not provided
disease_stage
not provided
ethnicity
not provided
health_state
not provided
karyotype
not provided
phenotype
not provided
population
not provided
race
not provided
sample_type
not provided
treatment
Enito250
BioSampleModel
Human